World's Best Scientists 2026 revealed!
Eric Legius

Eric Legius

Award Badge
Biology and Biochemistry
Belgium
2023

D-Index & Metrics

Biology and Biochemistry

D-Index
87
Citations
24945
World Ranking
2860
National Ranking
42

Medicine

D-Index
89
Citations
25968
World Ranking
12792
National Ranking
150

Eric Legius publication distribution in Biology and Biochemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Biology and Biochemistry in 2026. The highlighted bar marks where Eric Legius sits on this spectrum.

47–56 publications: 8 scientists 57–66 publications: 35 scientists 67–76 publications: 106 scientists 77–86 publications: 231 scientists 87–96 publications: 414 scientists 97–106 publications: 546 scientists 107–116 publications: 704 scientists 117–126 publications: 849 scientists 127–136 publications: 980 scientists 137–146 publications: 942 scientists 147–156 publications: 969 scientists 157–166 publications: 950 scientists 167–176 publications: 951 scientists 177–186 publications: 915 scientists 187–196 publications: 787 scientists 197–206 publications: 841 scientists 207–216 publications: 735 scientists 217–226 publications: 709 scientists 227–236 publications: 651 scientists 237–246 publications: 605 scientists 247–256 publications: 510 scientists 257–266 publications: 524 scientists 267–276 publications: 434 scientists 277–286 publications: 418 scientists 287–296 publications: 350 scientists 297–306 publications: 363 scientists 307–316 publications: 315 scientists 317–326 publications: 296 scientists 327–336 publications: 261 scientists 337–346 publications: 240 scientists 347–356 publications: 219 scientists 357–366 publications: 197 scientists 367–376 publications: 154 scientists 377–386 publications: 161 scientists 387–396 publications: 155 scientists 397–406 publications: 145 scientists 407–416 publications: 124 scientists 417–426 publications: 112 scientists 427–436 publications: 132 scientists 437–446 publications: 116 scientists 447–456 publications: 99 scientists 457–466 publications: 81 scientists 467–476 publications: 91 scientists 477–486 publications: 80 scientists 487–496 publications: 80 scientists 497–506 publications: 60 scientists 507–516 publications: 36 scientists 517–526 publications: 46 scientists 527–536 publications: 54 scientists 537–546 publications: 44 scientists 547–556 publications: 43 scientists 557–566 publications: 43 scientists 567–576 publications: 42 scientists 577–586 publications: 25 scientists 587–596 publications: 34 scientists 597–606 publications: 23 scientists 607–616 publications: 33 scientists 617–626 publications: 31 scientists 627–636 publications: 27 scientists 637–646 publications: 25 scientists 647–656 publications: 28 scientists 657–666 publications: 34 scientists 667–676 publications: 18 scientists 677–686 publications: 16 scientists 687–696 publications: 10 scientists 697–706 publications: 12 scientists 707–716 publications: 21 scientists 717–726 publications: 12 scientists 727–736 publications: 12 scientists 737–746 publications: 10 scientists 747–756 publications: 7 scientists 757–766 publications: 13 scientists 767–776 publications: 15 scientists 777–786 publications: 13 scientists 787–796 publications: 9 scientists 797–806 publications: 9 scientists 807–816 publications: 7 scientists 817–826 publications: 4 scientists 827–836 publications: 9 scientists 837–846 publications: 7 scientists 847–856 publications: 3 scientists 857–866 publications: 5 scientists 867–876 publications: 5 scientists 877–886 publications: 11 scientists 887–896 publications: 3 scientists 897–906 publications: 4 scientists 907–916 publications: 7 scientists 917–926 publications: 5 scientists 927–936 publications: 6 scientists 937–946 publications: 6 scientists 947–956 publications: 3 scientists 957–966 publications: 7 scientists 967–976 publications: 2 scientists 977–986 publications: 2 scientists 987–996 publications: 1 scientists 997–1,006 publications: 5 scientists 1,007–1,016 publications: 2 scientists 1,017–1,026 publications: 2 scientists 1,027 publications: 1 scientists 1,028+ publications: 100 scientists
47 publications 1,028+

This scientist: 430 publications — 92nd percentile

92% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,028 publications or more.

Eric Legius D-index placement in Biology and Biochemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Biology and Biochemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Eric Legius sits on this spectrum.

40–41 D-Index: 80 scientists 42–43 D-Index: 183 scientists 44–45 D-Index: 317 scientists 46–47 D-Index: 504 scientists 48–49 D-Index: 718 scientists 50–51 D-Index: 900 scientists 52–53 D-Index: 1,026 scientists 54–55 D-Index: 1,150 scientists 56–57 D-Index: 1,236 scientists 58–59 D-Index: 1,253 scientists 60–61 D-Index: 1,163 scientists 62–63 D-Index: 1,131 scientists 64–65 D-Index: 1,032 scientists 66–67 D-Index: 897 scientists 68–69 D-Index: 814 scientists 70–71 D-Index: 715 scientists 72–73 D-Index: 709 scientists 74–75 D-Index: 596 scientists 76–77 D-Index: 512 scientists 78–79 D-Index: 473 scientists 80–81 D-Index: 412 scientists 82–83 D-Index: 373 scientists 84–85 D-Index: 358 scientists 86–87 D-Index: 285 scientists 88–89 D-Index: 273 scientists 90–91 D-Index: 227 scientists 92–93 D-Index: 208 scientists 94–95 D-Index: 193 scientists 96–97 D-Index: 153 scientists 98–99 D-Index: 157 scientists 100–101 D-Index: 148 scientists 102–103 D-Index: 120 scientists 104–105 D-Index: 113 scientists 106–107 D-Index: 100 scientists 108–109 D-Index: 86 scientists 110–111 D-Index: 67 scientists 112–113 D-Index: 72 scientists 114–115 D-Index: 73 scientists 116–117 D-Index: 64 scientists 118–119 D-Index: 53 scientists 120–121 D-Index: 60 scientists 122–123 D-Index: 54 scientists 124–125 D-Index: 43 scientists 126–127 D-Index: 38 scientists 128–129 D-Index: 49 scientists 130–131 D-Index: 26 scientists 132–133 D-Index: 18 scientists 134–135 D-Index: 23 scientists 136–137 D-Index: 32 scientists 138–139 D-Index: 32 scientists 140–141 D-Index: 27 scientists 142–143 D-Index: 19 scientists 144–145 D-Index: 22 scientists 146–147 D-Index: 12 scientists 148–149 D-Index: 16 scientists 150–151 D-Index: 14 scientists 152–153 D-Index: 10 scientists 154–155 D-Index: 13 scientists 156–157 D-Index: 10 scientists 158–159 D-Index: 7 scientists 160–161 D-Index: 9 scientists 162–163 D-Index: 13 scientists 164–165 D-Index: 4 scientists 166 D-Index: 4 scientists 167+ D-Index: 98 scientists
40 D-Index 167+

This scientist: 87 D-Index — 86th percentile

86% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 167 D-Index or more.

Research.com Recognitions

  • 2023 - Research.com Biology and Biochemistry in Belgium Leader Award

Overview

Eric Legius is affiliated with KU Leuven in Belgium, conducting research primarily in the fields of Medicine and Biochemistry, Genetics and Molecular Biology. They have a strong focus on Molecular Biology, Genetics, Neurology, Rheumatology, and Epidemiology, contributing extensively to areas related to neurofibromatosis, schwannoma cases, and other genetic disorders.

Their main research topics include:

  • Neurofibromatosis and Schwannoma Cases
  • Meningioma and schwannoma management
  • Genomic variations and chromosomal abnormalities
  • Bone Tumor Diagnosis and Treatments
  • Prenatal Screening and Diagnostics
  • Genetics and Neurodevelopmental Disorders
  • Soft tissue tumors and treatment

Eric Legius has published papers in several key venues, including Genetics in Medicine, European Journal of Human Genetics, Annals of Oncology, EClinicalMedicine, and European Journal of Medical Genetics. Genetics in Medicine and the European Journal of Human Genetics are notable for being the venues with the highest number of their publications.

Some of their recent publications include:

  • Revised diagnostic criteria for neurofibromatosis type 1 and Legius syndrome: an international consensus recommendation, 2021, Genetics in Medicine
  • Soft tissue and visceral sarcomas: ESMO-EURACAN-GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up, 2021, Annals of Oncology
  • Gastrointestinal stromal tumours: ESMO-EURACAN-GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up, 2021, Annals of Oncology
  • Bone sarcomas: ESMO-EURACAN-GENTURIS-ERN PaedCan Clinical Practice Guideline for diagnosis, treatment and follow-up, 2021, Annals of Oncology
  • Updated diagnostic criteria and nomenclature for neurofibromatosis type 2 and schwannomatosis: An international consensus recommendation, 2022, Genetics in Medicine

Frequent co-authors collaborating with Legius include Hilde Brems, Rianne Oostenbrink, D. Gareth Evans, Rosalie E. Ferner, and P. Wolkenstein. These collaborations reflect a network of professionals engaged in overlapping fields of genetics and clinical research.

Best Publications

  • SOX10 mutations in patients with Waardenburg-Hirschsprung disease.

    Véronique Pingault;Nadège Bondurand;Kirsten Kuhlbrodt;Derk E. Goerich

  • A combined syndrome of juvenile polyposis and hereditary haemorrhagic telangiectasia associated with mutations in MADH4 (SMAD4).

    Carol J Gallione;Gabriela M Repetto;Eric Legius;Anil K Rustgi

  • The NF1 tumor suppressor critically regulates TSC2 and mTOR

    Cory M. Johannessen;Elizabeth E. Reczek;Marianne F. James;Hilde Brems

  • Neurofibromatosis type 1

    Legius E;Descheemaeker Mj;Fryns Jp;Van den Berghe H

  • Germline loss-of-function mutations in SPRED1 cause a neurofibromatosis 1-like phenotype.

    Hilde Brems;Magdalena Chmara;Magdalena Chmara;Mourad Sahbatou;Ellen Denayer

  • Somatic deletion of the neurofibromatosis type 1 gene in a neurofibrosarcoma supports a tumour suppressor gene hypothesis.

    Eric Legius;Eric Legius;Douglas A. Marchuk;Francis S. Collins;Thomas W. Glover

  • Revised diagnostic criteria for neurofibromatosis type 1 and Legius syndrome: an international consensus recommendation.

    E Legius;L Messiaen;P Wolkenstein;P Pancza

  • PRC2 loss amplifies Ras-driven transcription and confers sensitivity to BRD4-based therapies

    Thomas De Raedt;Eline Beert;Eric Pasmant;Armelle Luscan

  • Intelligence and psychosocial adjustment in velocardiofacial syndrome: a study of 37 children and adolescents with VCFS.

    Ann Swillen;Koenraad Devriendt;Eric Legius;Benedicte Eyskens

  • Mechanisms in the pathogenesis of malignant tumours in neurofibromatosis type 1

    Hilde Brems;Eline Beert;Thomy de Ravel;Eric Legius

  • Elevated risk for MPNST in NF1 microdeletion patients.

    T. De Raedt;H. Brems;P. Wolkenstein;D. Vidaud

  • Cognitive function and academic performance in neurofibromatosis 1 : Consensus statement from the NF1 Cognitive Disorders Task Force

    K. N. North;V. Riccardi;C. Samango-Sprouse;R. Ferner

  • Mutations in the CCN gene family member WISP3 cause progressive pseudorheumatoid dysplasia.

    J R Hurvitz;W M Suwairi;W Van Hul;H El-Shanti

  • PTPN11 mutations in LEOPARD syndrome

    Eric Legius;C Schrander-Stumpel;E Schollen;C Pulles-Heintzberger

  • Communication with close and distant relatives in the context of genetic testing for hereditary breast and ovarian cancer in cancer patients.

    Erna Claes;Gerry Evers-Kiebooms;Andrea Boogaerts;Marleen Decruyenaere

  • CNGB3 mutations account for 50% of all cases with autosomal recessive achromatopsia

    Susanne Kohl;Balazs Varsanyi;Balazs Varsanyi;Gesine Abadin Antunes;Britta Baumann

  • Molecular pathogenesis of multiple gastrointestinal stromal tumors in NF1 patients

    Ophélia Maertens;Hans Prenen;Maria Debiec-Rychter;Agnieszka Wozniak

  • Guidelines for the Li–Fraumeni and heritable TP53-related cancer syndromes

    Thierry Frebourg;Svetlana Bajalica Lagercrantz;Carla Oliveira;Rita Magenheim

  • Atypical Neurofibromas in Neurofibromatosis Type 1 Are Premalignant Tumors

    Eline Beert;Hilde Brems;Bruno Daniëls;Ivo De Wever

  • Intelligence and psychosocial adjustment in velo-cardio-facial syndrome: a study of 37 children and adolescents with VCFS

    Ann Swillen;Koenraad Devriendt;Eric Legius;B Eyskens

Frequent Co-Authors

Gert Matthijs
Gert Matthijs KU Leuven
Ludwine Messiaen
Ludwine Messiaen University of Alabama at Birmingham
Thomas D'Hooghe
Thomas D'Hooghe Yale University
Peter Marynen
Peter Marynen KU Leuven
Jean Steyaert
Jean Steyaert KU Leuven
Meena Upadhyaya
Meena Upadhyaya Cardiff University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Biology and Biochemistry in the USA opens doors to a diverse range of online degree programs and dynamic career opportunities. If you’re interested in leadership within healthcare organizations, pursuing a phd in healthcare management can prepare you for upper-level roles in hospitals, clinics, and policy-making bodies.

For those aiming to work in pharmaceuticals, earning a pharmd online programs degree is a flexible way to become a licensed pharmacist or advance in pharmaceutical research. Meanwhile, students with an interest in human performance, fitness, or rehabilitation may find an online bachelor's degree in exercise science offers a strong foundation for careers in coaching, wellness, or allied health.

Additionally, the best online kinesiology degree programs focus on the movement of the human body, opening pathways in sports medicine, physical therapy, and more. Exploring these related online degrees can help you tailor your academic path and make strategic career choices in the biological and health sciences fields.

Best Scientists Citing Eric Legius

Trending Scientists

Recently Published Articles